YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Natco Pharma

Natco Pharma

BSE: 524816|NSE: NATCOPHARM|ISIN: INE987B01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 27, 16:00
1048.00
-8.75 (-0.83%)
VOLUME 18,572
LIVE
NSE
Jul 27, 15:57
1038.90
-18.5 (-1.75%)
VOLUME 726,724
News on Natco Pharma
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy NATCO Pharma; target Rs 265: Firstcall Research

11.54 am | 19 Dec 2011 |  Source: Moneycontrol.com

Firstcall Research is bullish on NATCO Pharma and has recommended buy rating on the stock with a target price of Rs 265 in its December 5, 2011 resear...

Bull's Eye: Short Kingfisher, ICICI Bank; buys Welspun Corp 

11.28 am | 13 Dec 2011 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

QIP funds will be used for capex: Natco Pharma 

11.35 am | 08 Dec 2011 |  Source: CNBC-TV18

In an intervies to CNBC-TV18, Bhaskar Narayana, finance director and chief financial officer of Natco Pharma spoke about the latest happenings in his ...

Bayer's growth plans: Eyes doubling India revenues by 2015 

6.12 pm | 16 Nov 2011 |  Source: CNBC-TV18

One of the most low key pharma companies Bayer AG today outlined its growth strategy in Asia and specifically in India, reports Archana Shukla of CNBC...

Natco Pharma Sep '11 sales at Rs 112.93 crore

7.19 pm | 10 Nov 2011 |  Source: Moneycontrol.com

Natco Pharma has reported a sales turnover of Rs 112.93 crore and a net profit of Rs 16.03 crore for the quarter ended Sep '11...

QIP of Rs 100cr to result in 7-8% dilution: Natco Pharma 

3.50 pm | 04 Nov 2011 |  Source: CNBC-TV18

Some agencies have been reporting that Natco Pharmas fund raising plan might be expedited and take place in the next one or two months. Finance direc...

Will make, sell products in bio-generic space: Natco Pharma 

4.18 pm | 18 Oct 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO of Natco Pharma talks about the pact with the Swiss based company and its imp...

Novartis tells SC it has right to patent blood cancer drug

8.21 pm | 09 Aug 2011 |  Source: PTI

Swiss pharma giant Novartis AG today told the Supreme Court it had the right to patent its blood cancer drug as it was a completely new medicine and n...

Lupin gets greedy, expects 14-15 launches this year 

3.44 pm | 23 Jun 2011 |  Source: CNBC-TV18

With a string of news coming from drug firm Lupin, the company further expects about 14 to 15 launches in the course of this year. Companys CFO, S Ra...

Lupin, Natco tie up to market breast cancer tablets

3.02 pm | 23 Jun 2011 |  Source: PTI

Drug firms Lupin Ltd and Natco Pharma today said that they have entered into an alliance to jointly market generic Lapatinib Ditosylate tablets, used ...

Natco to partner Lupin to market generic breast cancer drug

12.20 pm | 23 Jun 2011 |  Source: Moneycontrol.com

Hyderabad-based Natco Pharma has filed an abbreviated new drug application with US Food and Drugs Administration for a generic version of Lapatinib Di...

Natco Pharma to sell US pharma biz when opportunity knocks 

11.30 am | 28 Mar 2011 |  Source: CNBC-TV18

Bhaskar Narayana, Finance Director & CFO, Natco Pharma said that he no longer sees synergies with SaveMart Pharmacy existing. The revenue being genera...

Natco Pharma may sell US-based pharmacy store SaveMart 

10.20 am | 28 Mar 2011 |  Source: CNBC-TV18

In an interview on CNBC-TV18, Bhaskar Narayana, finance director and chief financial officer at Natco Pharma said that synergies with the SaveMart Pha...

Gilead, Roche's suit on expected lines: Natco Pharma 

4.29 pm | 16 Mar 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma said," In a patently challenged issue, the innovator is bound t...

Natco Pharma Dec '10 sales at Rs 90.99 crore

7.01 pm | 16 Feb 2011 |  Source: Moneycontrol.com

Natco Pharma has reported a sales turnover of Rs 90.99 crore and a net profit of Rs 12.40 crore for the quarter ended Dec '10...

Natco Pharma eyes 9-10% revenue growth in FY11 

3.44 pm | 15 Feb 2011

In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director and CFO, Natco Pharma, speaks about the results and gives his outlook going forward...

Natco Pharma Q3 net profit down at Rs 12.4 cr

2.36 pm | 14 Feb 2011 |  Source: CNBC-TV18

Natco Pharma has reported a net profit of Rs 12.4 crore for the quarter ended December 2010 as against Rs 12.9 crore in same quarter the previous year...

Natco Pharma challenges patent on Tamiflu

5.52 pm | 11 Feb 2011

Natco Pharma has challenged a patent on Tamiflu (Oseltamivir Phosphate)a drug used in the treatment of bird and swine-flu infections, reports the PTI...

At-risk launch likely for Tamiflu generic: Natco Pharma 

4.15 pm | 09 Feb 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma gave his perspective on the tie-up with Alvogen and the first-t...

Expect to cross Rs 500cr in revenue this yr: Natco Pharma 

3.54 pm | 10 Jan 2011 |  Source: CNBC-TV18

Hyderabad-based Natco Pharma has sought permission from drug major Pfizer to sell discounted copies of its HIV drug. In an interview with CNBC-TV18, B...

1 2
Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.